Technology

Evaluating the PTO’s Proposed Fee Structure

Evaluating the PTO’s Proposed Fee Structure

Proposed fee structure remains flawed and may contribute to the perception of a “broken” patent system.

Expanding Child Protection Online

Expanding Child Protection Online

FTC proposes to “clarify” and “strengthen” online children’s privacy.

Better Informing the Net Neutrality Debate

Better Informing the Net Neutrality Debate

Penn Law Professor argues for “network diversity” rather than “network neutrality.”

Smartphone Patent Wars: The Role for Import Bans

Smartphone Patent Wars: The Role for Import Bans

Congress holds hearings on the role of import bans in licensing of standard essential patents.

Senate Bills Aim to Help Graduates in STEM Fields Get Green Cards

Senate Bills Aim to Help Graduates in STEM Fields Get Green Cards

Supporters of Senate Bills on STEM say US needs skilled immigrants.

FCC Seeks Comments on Proposed Rule for Public Safety Do-Not-Call List

FCC Seeks Comments on Proposed Rule for Public Safety Do-Not-Call List

The FCC seeks input on how to manage and enforce a Do-Not-Call Registry for emergency service lines.

Valuing the Rear-view Camera Rule

Valuing the Rear-view Camera Rule

NHTSA’s analysis cannot support its conclusion that the benefits justify the costs.

Senate Hears Testimony on a Potential Helium Crisis

Senate Hears Testimony on a Potential Helium Crisis

Witnesses urge Congress to act or face a helium shortage.

The Value of Increasing Unlicensed Spectrum

The Value of Increasing Unlicensed Spectrum

Increasing unlicensed spectrum could increase social welfare.

The Apple E-Books Litigation: A Page-Turner

The Apple E-Books Litigation: A Page-Turner

Allegations in complaints befit a conspiracy novel – one that Apple argues is completely fictional.

Coalition Calls for Increased Oversight of Synthetic Biology

Coalition Calls for Increased Oversight of Synthetic Biology

Advocacy groups say current regulation of synthetic biology offers inadequate public protection.

Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges

Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges

Challenges to branded drugs from generic firms have benefits and costs.